Empowered Patient Podcast

Karen Jagoda
  • 4,9 (16)
  • Y HỌC
  • HẰNG NGÀY
Empowered Patient Podcast

Empowered Patient Podcast with Karen Jagoda is a window into the latest innovations in digital health, the changing dynamic between doctors and patients, and the emergence of precision medicine. The show covers such topics as aging in place, innovative uses for wearables and sensors, advances in clinical research, applied genetics, drug development, and challenges for connected health entrepreneurs.

  1. 1 NGÀY TRƯỚC · NỘI DUNG TẶNG THÊM

    Advancing Hearing Health with Implantable Devices with Brent Lucas Envoy Medical TRANSCRIPT

    Brent Lucas, CEO of Envoy Medical, highlights the lack of innovation in hearing aids and the need to better address hearing health. Envoy has developed fully implanted hearing devices that provide 24/7 hearing assistance without the need for daily recharging of the battery.  With the introduction of over-the-counter hearing aids and the advanced Apple AirPods Pro 2, customer options have been expanded, making it easier to address some forms of hearing loss. Implanted devices eliminate the limitations of external hearing aids and reduce the impact of hearing loss on their daily lives. Brent explains, "Part of the problem in the hearing loss industry has been that it's not well understood. So there has not been a great deal of competition and innovation in the hearing loss world. Most of us have thought about hearing loss and how it's addressed by looking to our grandparents, the elders. Plenty of people joke about our dads or our grandfathers not being able to hear our grandmothers. When I tell people I'm in the hearing industry, the first thing that they say is, I can't hear you. And I always fall for it. And I say, I'm in the hearing industry, and they come clean that it was a joke. At the end of the day, there are unmet needs in finding solutions for people that are not just the status quo. That's really where Envoy Medical is building products that are fully implanted, in a sense, a better life because they're not tied to their hearing loss." "Right now, the current solutions on the market are all external products that need to be taken off at night or around water in the shower, during strenuous activity, working out, sweating too much, that sort of thing. You have to take your external device off. Our devices are fully implanted, meaning you can be capable of hearing 24/7, hearing all day, every day. We think that's the right thing to do for a patient because your hearing loss, after all, is a 24-hour problem. It shouldn't be that your solution is only on for part of the day."  #EnvoyMedical #HearingLoss #Acclaim #HearingAids #CochlearImplant $COCH #HearingHealth  envoymedical.com Listen to the podcast here

  2. 1 NGÀY TRƯỚC

    Advancing Hearing Health with Implantable Devices with Brent Lucas Envoy Medical

    Brent Lucas, CEO of Envoy Medical, highlights the lack of innovation in hearing aids and the need to better address hearing health. Envoy has developed fully implanted hearing devices that provide 24/7 hearing assistance without the need for daily recharging of the battery.  With the introduction of over-the-counter hearing aids and the advanced Apple AirPods Pro 2, customer options have been expanded, making it easier to address some forms of hearing loss. Implanted devices eliminate the limitations of external hearing aids and reduce the impact of hearing loss on their daily lives. Brent explains, "Part of the problem in the hearing loss industry has been that it's not well understood. So there has not been a great deal of competition and innovation in the hearing loss world. Most of us have thought about hearing loss and how it's addressed by looking to our grandparents, the elders. Plenty of people joke about our dads or our grandfathers not being able to hear our grandmothers. When I tell people I'm in the hearing industry, the first thing that they say is, I can't hear you. And I always fall for it. And I say, I'm in the hearing industry, and they come clean that it was a joke. At the end of the day, there are unmet needs in finding solutions for people that are not just the status quo. That's really where Envoy Medical is building products that are fully implanted, in a sense, a better life because they're not tied to their hearing loss." "Right now, the current solutions on the market are all external products that need to be taken off at night or around water in the shower, during strenuous activity, working out, sweating too much, that sort of thing. You have to take your external device off. Our devices are fully implanted, meaning you can be capable of hearing 24/7, hearing all day, every day. We think that's the right thing to do for a patient because your hearing loss, after all, is a 24-hour problem. It shouldn't be that your solution is only on for part of the day."  #EnvoyMedical #HearingLoss #Acclaim #HearingAids #CochlearImplant $COCH #HearingHealth  envoymedical.com Download the transcript here

    25 phút

  3. 1 NGÀY TRƯỚC · NỘI DUNG TẶNG THÊM

    How AI Can Streamline Hospital Workflow and Improve Patient Care with Caleb Manscill Vyne Medical TRANSCRIPT

    Caleb Manscill, President of Vyne Medical, has a mission to present a holistic view of data, from origination to use, within a healthcare organization. The goal is to guide them to find ways to streamline the workflow, save time, reduce errors and costs, and improve patient outcomes. Using AI to handle faxes, data entry, and other administrative tasks can free up staff to handle issues that require human intervention. Vyne Medical provides insights about implementing technology and overcoming cultural resistance to changes in healthcare organizations.  Caleb explains, "We've got multiple use cases, but I'll speak to two. The first one is the simple handling of faxes. There's lots of unstructured data coming into different points of care. In this case, I'll talk about the hospital, but there are lots of referrals being made. There are lab reports being sent and there's data that needs to be appended through HIM. Often, this data will come in through the fax machine as unstructured data, and individuals will pick up this paper. And we're talking, again, going back to the paper and picking it up and keying it in. There's the risk, not to mention miskeying it or accuracy. Still, that process is potentially taking place anywhere. If it's a simple patient order, it could take a few minutes. If it's an extensive lab report, it could take upwards of 20 minutes. The automation or AI utilized within our product suite and platform can take that down to 30 seconds or even just a few seconds, depending on the workflow that needs to be initiated."   "That's why we exist in that very specific use case of fax management. The way that our solution works is it streamlines the whole process so that there isn't any paper handling. So it's almost as if it's being sent electronically, through the internet, or however you want it to be. What's most important to us is that if they're not going to change their behavior, at least we can meet them where they are and streamline it as if they had adopted the most up-to-date APIs or ways of sending those data." #VyneMedical #Workflow #Hospitals #Automation #HospitalWorkflow vynemedical.com Listen to the podcast here

  4. 1 NGÀY TRƯỚC

    How AI Can Streamline Hospital Workflow and Improve Patient Care with Caleb Manscill Vyne Medical

    Caleb Manscill, President of Vyne Medical, has a mission to present a holistic view of data, from origination to use, within a healthcare organization. The goal is to guide them to find ways to streamline the workflow, save time, reduce errors and costs, and improve patient outcomes. Using AI to handle faxes, data entry, and other administrative tasks can free up staff to handle issues that require human intervention. Vyne Medical provides insights about implementing technology and overcoming cultural resistance to changes in healthcare organizations.  Caleb explains, "We've got multiple use cases, but I'll speak to two. The first one is the simple handling of faxes. There's lots of unstructured data coming into different points of care. In this case, I'll talk about the hospital, but there are lots of referrals being made. There are lab reports being sent and there's data that needs to be appended through HIM. Often, this data will come in through the fax machine as unstructured data, and individuals will pick up this paper. And we're talking, again, going back to the paper and picking it up and keying it in. There's the risk, not to mention miskeying it or accuracy. Still, that process is potentially taking place anywhere. If it's a simple patient order, it could take a few minutes. If it's an extensive lab report, it could take upwards of 20 minutes. The automation or AI utilized within our product suite and platform can take that down to 30 seconds or even just a few seconds, depending on the workflow that needs to be initiated."   "That's why we exist in that very specific use case of fax management. The way that our solution works is it streamlines the whole process so that there isn't any paper handling. So it's almost as if it's being sent electronically, through the internet, or however you want it to be. What's most important to us is that if they're not going to change their behavior, at least we can meet them where they are and streamline it as if they had adopted the most up-to-date APIs or ways of sending those data." #VyneMedical #Workflow #Hospitals #Automation #HospitalWorkflow vynemedical.com Download the transcript here

    20 phút

  5. 1 NGÀY TRƯỚC · NỘI DUNG TẶNG THÊM

    Using AI-Powered Diagnostics to Identify Optimal Therapies for Prostate Cancer with Andre Esteva Artera TRANSCRIPT

    Andre Esteva is the CEO and Co-Founder of Artera, a company focused on improving prostate cancer diagnostics. The company uses an AI-driven test, validated in large-scale clinical trials, to analyze a tumor biopsy or surgical specimen and predict response to therapy and likely long-term outcomes. This helps inform treatment decisions, reduce the risk of over-treatment, and support healthcare equity in diverse patient populations. Plans are underway to expand the AI-driven diagnostic tools to other solid tumor types leveraging the ability of AI to learn across different cancers.   Andre explains, "In general, when it comes to the treatment of prostate cancer, and this is true for most cancers, clinicians tend to be conservative, rightfully so, and there is a tendency to overtreat patients. You see, when it comes to assigning a therapy to a patient, there's this notion of the optimal therapy, and you want to get it right. If you undertreat your patient, the disease will progress, and nobody wants their cancer to progress. So as a result, patients tend to be overtreated when too much therapy is applied. While that does support killing the cancer, it also comes with a series of negative side effects. Real toxicities occur, and this is especially true in the case of prostate cancer."  "The ArteraAI test is an AI that will look at an image of a patient's tumor, specifically a digitized image of the patient's histopathology of a biopsy or surgical specimen. It will look at all the patient's cells and the tumor morphology and the tumor microenvironment, everything else that you'll see on a histopathology slide in the form of a digital image. From that, it'll generate a report for the patient's clinician with two pieces of really important information on it. The first piece is how that patient will respond to therapy. The AI will predict the response to therapy. The second piece is prognostic information. So, the AI will prognosticate patient outcomes. Outcomes here mean will the patient's cancer metastasize in the next five or 10 years, will the patient die of cancer, will dangerous biochemical levels recur in time and so forth. And in doing so, we help to inform treatments." #Artera #MedAI #AI #ProstateCancer #CancerDiagnostics #Tumors #HealthEquity artera.ai Listen to the podcast here

  6. 1 NGÀY TRƯỚC

    Using AI-Powered Diagnostics to Identify Optimal Therapies for Prostate Cancer with Andre Esteva Artera

    Andre Esteva is the CEO and Co-Founder of Artera, a company focused on improving prostate cancer diagnostics. The company uses an AI-driven test, validated in large-scale clinical trials, to analyze a tumor biopsy or surgical specimen and predict response to therapy and likely long-term outcomes. This helps inform treatment decisions, reduce the risk of over-treatment, and support healthcare equity in diverse patient populations. Plans are underway to expand the AI-driven diagnostic tools to other solid tumor types leveraging the ability of AI to learn across different cancers.   Andre explains, "In general, when it comes to the treatment of prostate cancer, and this is true for most cancers, clinicians tend to be conservative, rightfully so, and there is a tendency to overtreat patients. You see, when it comes to assigning a therapy to a patient, there's this notion of the optimal therapy, and you want to get it right. If you undertreat your patient, the disease will progress, and nobody wants their cancer to progress. So as a result, patients tend to be overtreated when too much therapy is applied. While that does support killing the cancer, it also comes with a series of negative side effects. Real toxicities occur, and this is especially true in the case of prostate cancer."  "The ArteraAI test is an AI that will look at an image of a patient's tumor, specifically a digitized image of the patient's histopathology of a biopsy or surgical specimen. It will look at all the patient's cells and the tumor morphology and the tumor microenvironment, everything else that you'll see on a histopathology slide in the form of a digital image. From that, it'll generate a report for the patient's clinician with two pieces of really important information on it. The first piece is how that patient will respond to therapy. The AI will predict the response to therapy. The second piece is prognostic information. So, the AI will prognosticate patient outcomes. Outcomes here mean will the patient's cancer metastasize in the next five or 10 years, will the patient die of cancer, will dangerous biochemical levels recur in time and so forth. And in doing so, we help to inform treatments." #Artera #MedAI #AI #ProstateCancer #CancerDiagnostics #Tumors #HealthEquity artera.ai Download the transcript here

    19 phút

  7. 2 NGÀY TRƯỚC · NỘI DUNG TẶNG THÊM

    Adults with Type 1 Diabetes Get Access to Comprehensive Support to Address Unmet Needs with Len D’Avolio Blue Circle Health TRANSCRIPT

    Len D'Avolio is the CEO of Blue Circle Health a program launched with the support of the Helmsley Charitable Trust to provide care, education, and support to adults with type 1 diabetes. The program provides free, remote support for 6 months including access to continuous glucose monitors, endocrinologists, counseling, insurance navigation, and affordable insulin and clinical care. The program aims to address the care gaps that exists for people with T1D and support them to better manage their condition.   Len explains, "The Helmsley Charitable Trust, which is a major philanthropic donor to the space dedicated to improving the lives of people with T1D, basically recognized that there's this big care gap between what people with T1D need to live healthy lives and what the US healthcare system tends to provide, based on what is or isn't reimbursable. So, they gathered a bunch of experts and conducted a number of focus groups and decided they'd like to close that gap. They formed Blue Circle Health as a free care education and support program designed to work with folks for about six months, trying to empower and educate them and close the gap."   "Education itself is not as widely reimbursed as it should be, and this particular condition requires a thousand more decisions a day than the average person dealing with a health problem because you're playing the role of your pancreas. You're having to understand your blood glucose levels, the foods you're about to eat, and then it's one of the few diseases in which we ask people to measure out and administer a potentially deadly bolus of drugs many times a day." #BlueCircleHealth #T1D #Type1 #Type1Diabetes #DiabetesAwareness #CGM #TypeOneDiabetes #TypeOne #EmpoweredPatient #Florida #Ohio #Delaware #Maine #Vermont bluecirclehealth.org Listen to the podcast here

  8. 2 NGÀY TRƯỚC

    Adults with Type 1 Diabetes Get Access to Comprehensive Support to Address Unmet Needs with Len D’Avolio Blue Circle Health

    Len D'Avolio is the CEO of Blue Circle Health a program launched with the support of the Helmsley Charitable Trust to provide care, education, and support to adults with type 1 diabetes. The program provides free, remote support for 6 months including access to continuous glucose monitors, endocrinologists, counseling, insurance navigation, and affordable insulin and clinical care. The program aims to address the care gaps that exists for people with T1D and support them to better manage their condition.   Len explains, "The Helmsley Charitable Trust, which is a major philanthropic donor to the space dedicated to improving the lives of people with T1D, basically recognized that there's this big care gap between what people with T1D need to live healthy lives and what the US healthcare system tends to provide, based on what is or isn't reimbursable. So, they gathered a bunch of experts and conducted a number of focus groups and decided they'd like to close that gap. They formed Blue Circle Health as a free care education and support program designed to work with folks for about six months, trying to empower and educate them and close the gap."   "Education itself is not as widely reimbursed as it should be, and this particular condition requires a thousand more decisions a day than the average person dealing with a health problem because you're playing the role of your pancreas. You're having to understand your blood glucose levels, the foods you're about to eat, and then it's one of the few diseases in which we ask people to measure out and administer a potentially deadly bolus of drugs many times a day." #BlueCircleHealth #T1D #Type1 #Type1Diabetes #DiabetesAwareness #CGM #TypeOneDiabetes #TypeOne #EmpoweredPatient #Florida #Ohio #Delaware #Maine #Vermont bluecirclehealth.org Download the transcript here

    21 phút
Xem tất cả (2 N)

4,9
/5
16 Xếp hạng

Giới Thiệu

Empowered Patient Podcast with Karen Jagoda is a window into the latest innovations in digital health, the changing dynamic between doctors and patients, and the emergence of precision medicine. The show covers such topics as aging in place, innovative uses for wearables and sensors, advances in clinical research, applied genetics, drug development, and challenges for connected health entrepreneurs.

Thông Tin

  • Nhà sáng tạo
    Karen Jagoda
  • Năm hoạt động
    2015 - 2024
  • Tập
    2 N
  • Xếp hạng
    Sạch
  • Bản quyền
    © 2024
  • Trang web chương trình
    Empowered Patient Podcast

Bạn cần đăng nhập để nghe các tập có chứa nội dung thô tục.

Luôn cập nhật thông tin về chương trình này

Đăng nhập hoặc đăng ký để theo dõi các chương trình, lưu các tập và nhận những thông tin cập nhật mới nhất.
Chọn quốc gia hoặc vùng

Châu Phi, Trung Đông và Ấn Độ

Châu Á Thái Bình Dương

Châu Âu

Châu Mỹ Latinh và Caribê

Hoa Kỳ và Canada